Cargando…

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy

Detalles Bibliográficos
Autores principales: Cavelti-Weder, Claudia, Muggli, Bettina, Keller, Cornelia, Babians-Brunner, Andrea, Biason-Lauber, Anna, Donath, Marc Y., Schmid-Grendelmeier, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357226/
https://www.ncbi.nlm.nih.gov/pubmed/22619293
http://dx.doi.org/10.2337/dc12-0115
_version_ 1782233640568094720
author Cavelti-Weder, Claudia
Muggli, Bettina
Keller, Cornelia
Babians-Brunner, Andrea
Biason-Lauber, Anna
Donath, Marc Y.
Schmid-Grendelmeier, Peter
author_facet Cavelti-Weder, Claudia
Muggli, Bettina
Keller, Cornelia
Babians-Brunner, Andrea
Biason-Lauber, Anna
Donath, Marc Y.
Schmid-Grendelmeier, Peter
author_sort Cavelti-Weder, Claudia
collection PubMed
description
format Online
Article
Text
id pubmed-3357226
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-33572262013-06-01 Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy Cavelti-Weder, Claudia Muggli, Bettina Keller, Cornelia Babians-Brunner, Andrea Biason-Lauber, Anna Donath, Marc Y. Schmid-Grendelmeier, Peter Diabetes Care Diabetes Care Electronic Pages American Diabetes Association 2012-06 2012-05-11 /pmc/articles/PMC3357226/ /pubmed/22619293 http://dx.doi.org/10.2337/dc12-0115 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Diabetes Care Electronic Pages
Cavelti-Weder, Claudia
Muggli, Bettina
Keller, Cornelia
Babians-Brunner, Andrea
Biason-Lauber, Anna
Donath, Marc Y.
Schmid-Grendelmeier, Peter
Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
title Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
title_full Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
title_fullStr Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
title_full_unstemmed Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
title_short Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
title_sort successful use of omalizumab in an inadequately controlled type 2 diabetic patient with severe insulin allergy
topic Diabetes Care Electronic Pages
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357226/
https://www.ncbi.nlm.nih.gov/pubmed/22619293
http://dx.doi.org/10.2337/dc12-0115
work_keys_str_mv AT caveltiwederclaudia successfuluseofomalizumabinaninadequatelycontrolledtype2diabeticpatientwithsevereinsulinallergy
AT mugglibettina successfuluseofomalizumabinaninadequatelycontrolledtype2diabeticpatientwithsevereinsulinallergy
AT kellercornelia successfuluseofomalizumabinaninadequatelycontrolledtype2diabeticpatientwithsevereinsulinallergy
AT babiansbrunnerandrea successfuluseofomalizumabinaninadequatelycontrolledtype2diabeticpatientwithsevereinsulinallergy
AT biasonlauberanna successfuluseofomalizumabinaninadequatelycontrolledtype2diabeticpatientwithsevereinsulinallergy
AT donathmarcy successfuluseofomalizumabinaninadequatelycontrolledtype2diabeticpatientwithsevereinsulinallergy
AT schmidgrendelmeierpeter successfuluseofomalizumabinaninadequatelycontrolledtype2diabeticpatientwithsevereinsulinallergy